Factor V activity in apheresis platelets: Implications for management of FV deficiency.

CONCLUSION: Plasma should be considered over PLTs as first-line therapy for non-complex FV deficiency-associated hemorrhage. If PLTs are considered for transfusion, plasma-only PLT units should be preferentially utilized, as PAS-C PLT have near-absent FV activity. PMID: 33166428 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33166428?dopt=Abstract

Source: Transfusion - November 9, 2020 Category: Hematology Authors: Gupta GK, Hendrickson JE, Bahel P, Siddon AJ, Rinder HM, Tormey CA Tags: Transfusion Source Type: research

More News: Hematology | Statistics | Students | Study | Universities & Medical Training